TITLE

Predictors of switching antipsychotic medications in the treatment of schizophrenia

AUTHOR(S)
Nyhuis, Allen W.; Faries, Douglas E.; Ascher-Svanum, Haya; Stauffer, Virginia L.; Kinon, Bruce J.
PUB. DATE
January 2010
SOURCE
BMC Psychiatry;2010, Vol. 10, p75
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: To identify patient characteristics and early changes in patients' clinical status that best predict subsequent switching of antipsychotic agents in the long-term treatment of schizophrenia. Methods: This post-hoc analysis used data from a one-year randomized, open-label, multisite study of antipsychotics in the treatment of schizophrenia. The study protocol permitted switching of antipsychotics when clinically warranted after the first eight weeks. Baseline patient characteristics were assessed using standard psychiatric measures and reviews of medical records. The prediction model included baseline sociodemographics, comorbid psychiatric and non-psychiatric conditions, body weight, clinical and functional variables, as well as change scores on standard efficacy and tolerability measures during the first two weeks of treatment. Cox proportional hazards modeling was used to identify the best predictors of switching from the initially assigned antipsychotic medication. Results: About one-third of patients (29.5%, 191/648) switched antipsychotics before the end of the one-year study. There were six variables identified as the best predictors of switching: lack of antipsychotic use in the prior year, pre-existing depression, female gender, lack of substance use disorder, worsening of akathisia (as measured by the Barnes Akathisia Scale), and worsening of symptoms of depression/anxiety (subscale score on the Positive and Negative Syndrome Scale) during the first two weeks of antipsychotic therapy. Conclusions: Switching antipsychotics appears to be prevalent in the naturalistic treatment of schizophrenia and can be predicted by a small and distinct set of variables. Interestingly, worsening of anxiety and depressive symptoms and of akathisia following two weeks of treatment were among the more robust predictors of subsequent switching of antipsychotics.
ACCESSION #
55091707

 

Related Articles

  • Depressive symptoms in first episode psychosis: a one-year follow-up study. Sönmez, Nasrettin; Romm, Kristin Lie; Andreasssen, Ole A.; Melle, Ingrid; Røssberg, Jan Ivar // BMC Psychiatry;2013, Vol. 13 Issue 1, p1 

    Background: Depressive symptoms are common in patients with first episode psychosis (FEP) and have serious consequences for them. The main aims of this study were to examine the course of depression in FEP patients and explore whether any patient characteristics at baseline predicts depressive...

  • Ethnicity and diagnostic patterns in veterans with psychoses. Blow, Frederic C.; Zeber, John E.; McCarthy, John F.; Valenstein, Marcia; Gillon, Leah; Bingham, C. Raymond // Social Psychiatry & Psychiatric Epidemiology;Oct2004, Vol. 39 Issue 10, p841 

    Background Differential diagnosis of schiz- ophrenia and bipolar disorder is a challenging but important task. These conditions often exhibit overlapping clinical symptomatology, but have different prognoses and pharmacological management strategies. Factors other than clinical presentation may...

  • Stress as a Predictor in Schizophrenia. Wallis, Geoffrey G. // British Journal of Psychiatry;Jan72, Vol. 120 Issue 554, p96 

    The article presents an abstract of the article "Stress as a Predictor in Schizophrenia," by G. G. Wallis. According to this study, every patient invalided from the Royal Navy with the diagnosis of schizophrenia between 1947 and 1956 was scored as objectively as possible for service, family,...

  • Public stigma and schizophrenia in São Paulo city. Peluso, Érica Toledo Piza; Blay, Sérgio Luís // Revista Brasileira de Psiquiatria;jun2011, Vol. 33 Issue 2, p130 

    Objective: To assess public stigma in relation to people with schizophrenia and possible factors associated with this phenomenon. Method: A cross-sectional study was conducted with a probabilistic sample of 500 individuals who live in the city of Sao Paulo, Brazil, and are aged between 18 and 65...

  • Are Paranoids Schizophrenics? Foulds, G. A.; Owen, Anna // British Journal of Psychiatry;Sep63, Vol. 109 Issue 462, p674 

    The article presents a study which categorizes paranoids on a scale of non-integrated psychosis with basis on several independent measures. Researchers have administered psychological tests such as the Runwell Symptom-Sign Inventory, Hysteroid-Obsessoid Questionnaire, and the Punitive Scales to...

  • DEPRESSION `REVEALED' IN SCHIZOPHRENIA. Hirsch, Steven R. // British Journal of Psychiatry;Apr82, Vol. 140, p421 

    The article comments on the association of depressive symptoms in schizophrenics with neuroleptic medication. The concept of pharmacogenic depression and akinetic depression are considered with the results of surveys. The concept of pharmacogenic depression assumes that depressive symptoms are a...

  • Depression in Schizophrenia: A Study of Prevalence and Treatment. Elk, A.; Dickman, B. J.; Teggin, A. F. // British Journal of Psychiatry;Aug86, Vol. 149, p228 

    In an investigation of white, coloured, and black patients admitted to a psychiatric hospital, the prevalence and treatment of depression in schizophrenia was assessed and found to be 30% in group of acute, nuclear schizophrenics. While the prevalence was similar in the three groups, depression...

  • Living With Schizophrenia and Thriving in Remission: 10 Years of Stress and Crises. Cunningham, Robin // Brief Treatment & Crisis Intervention;Sep2002, Vol. 2 Issue 3, p247 

    This article, written by a consumer of mental health services, focuses on four intermittent series of crisis episodes, applicable for persons with schizophrenia or bipolar disorder, making it clear what lessons in crisis intervention the author learned from his clinician and/or family member....

  • Fluvoxamine may prevent onset of psychosis: a case report of a patient at ultra-high risk of psychotic disorder.  // Annals of General Psychiatry;2011, Vol. 10 Issue 1, p26 

    The article presents a case study of a 19-year-old Japanese man with psychotic disorder in whom fluvoxamine showed preventive effects on psychotic-like prodromal symptoms. As a result of treatment with 100 mg/day of fluvoxamine, the patient's depressive symptoms were reduced and maintained below...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics